New medications
For the companies developing projects in the following fields:
- targeted medications
- Biopharmaceuticals - monoclonal antibodies and its derivatives, medications based on autologous or allogeneic cells
Jury

Vadim Balabanyan
Lomonosov Moscow State University

Kira Blong
AstraZeneca

Polina Denisenko
Publika

Nadezhda Kartashova
the State Institute of Drugs and Good Practices (SID&GP)

Nadezhda Kartashova
the State Institute of Drugs and Good Practices (SID&GP)

Dmitry Kulish
Skoltech

Nataliya Mushenkova
Pharmstd Ventures

Dmitrii Ovchinnikov
SELECTA RUS

Elizaveta Rozhdestvenskaya
Primer Capital

Marina Sekacheva
Sechenov University

Arseniy Shabashvili
Freelance

Igor Tsvetkov
S-GROUP Corporate Communication Center

Kirill Volynchik
RVC InfraFund